Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Daiichi Sankyo
UBS
Cipla
Fish and Richardson

Generated: July 23, 2019

DrugPatentWatch Database Preview

Sotalol hydrochloride - Generic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

What are the generic sources for sotalol hydrochloride and what is the scope of sotalol hydrochloride patent protection?

Sotalol hydrochloride is the generic ingredient in five branded drugs marketed by Altathera Pharms Llc, Arbor Pharms Llc, Covis Pharma Bv, Upsher Smith Labs, Apotex, Apotex Inc, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford Pharms, Sun Pharm Industries, Teva, and Watson Labs, and is included in twenty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sotalol hydrochloride has one patent family member in one country.

There are ten drug master file entries for sotalol hydrochloride. Twenty-five suppliers are listed for this compound.

Summary for sotalol hydrochloride
Pharmacology for sotalol hydrochloride
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration
Medical Subject Heading (MeSH) Categories for sotalol hydrochloride
Synonyms for sotalol hydrochloride
( inverted question mark)-Sotalol hydrochloride
(?)-Sotalol hydrochloride
(+)-Sotalol hydrochloride
(+/-)-Sotalol hydrochloride
(+/-)-Sotalol hydrochloride, >=98% (TLC), powder
(+/-)-Sotalol hydrochloride, analytical standard
(y)-Sotalol hydrochloride
[(Isopropylamino)hydroxyethyl]methanesulfonanilide hydrochloride
3930-20-9 (Parent)
4 inverted exclamation mark -(1-hydroxy-2-(isopropylamino)ethyl)-methanesulfonanilidmonohydrochlorid
4 inverted exclamation mark -(1-hydroxy-2-(isopropylamino)ethyl)methanesulfonanilidemonohydrochloride
4-(2-Isopropylamino-1-hydroxyaethyl)methanesulfonailid hydrochlorid
4-(2-Isopropylamino-1-hydroxyaethyl)methanesulfonailid hydrochlorid [German]
4-(2-isopropylamino-1-hydroxyaethyl)methanesulfonailidhydrochlorid
4-[2-(Isopropylamine)-1-hydroxyethyl]methanesulfonanilide hydrochloride
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methanesulfonanilide monohydrochloride
4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulphonanilide hydrochloride
4'-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide hydrochloride
4'-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide monohydrochloride
4'-[2-(Isopropylamino)-1-hydroxyethyl]methanesulfonanilide hydrochloride
4'-[2-(Isopropylamino)-1-hydroxyethyl]methanesulfonanilide monohydrochloride
959-24-0
959S240
A845501
AB0012836
AB2000612
AC-3541
AC1L24Y9
AC1Q394B
AKOS015888287
AN-12879
AN-19653
API0006283
AS-13017
AX8089585
BC209131
BCP02975
BCP0726000245
Berlex
Berlex Laboratories
Betapace
Betapace (TN)
Betapace AF
Betapace AF;Berlex Laboratories;Sotalex;Betapace
BG0406
C12H20N2O3S.HCl
C12H21ClN2O3S
CAS-959-24-0
CCG-100907
CCG-213603
CHEBI:9207
CHEMBL1700
CPD000326828
CS-2543
CTK8G3175
D01026
DSSTox_CID_1278
DSSTox_GSID_21278
DSSTox_RID_76054
DTXSID8021278
EINECS 213-496-0
EU-0101055
FT-0603531
HMS1571A13
HY-B0437
I01-1040
Isopropylaminohydroxyethylmethanesulfonanilide hydrochloride
isopropylaminohydroxyethylmethanesulfonanilidehydrochloride
J10044
KM3383
KS-000011O8
LP01055
LS-7704
Mead johnson 1999
meadjohnson1999
Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-, monohydrochloride
Methanesulfonanilide, 4'-(1-hydroxy-2-(isopropylamino)ethyl)-, monohydrochloride
MFCD00242937
MJ 1999
MJ 1999 hydrochloride
MLS000758296
MLS000859969
MLS001401380
MLS002222318
MolPort-003-959-478
N-(2-hydroxy-2-{4-[(methylsulfonyl)amino]phenyl}ethyl)propan-2-aminium chloride
N-(4-(1-hydroxy-2-(isopropylamino)ethyl)phenyl)methanesulfonamide hydrochloride
N-(4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl)methanesulfonamide hydrochloride
N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide hydrochloride
N-(4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)methanesulfonamide hydrochloride
N-[4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide hydrochloride
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide hydrochloride
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
N-[4-[1-Hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide hydrochloride
N-[4-[1-oxidanyl-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide hydrochloride
N-{4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide hydrochloride
N-Isopropyl-.beta.-(4-methanesulfonamidophenyl)ethanolamine hydrochloride
N-Isopropyl-beta-(4-methanesulfonamidophenyl)ethanolamine hydrochloride
n-isopropyl-beta-(4-methanesulfonamidophenyl)ethanolaminehydrochloride
NC00157
NCGC00094337-01
NCGC00094337-02
NCGC00094337-03
NCGC00257681-01
NCGC00261740-01
NSC-337251
NSC-760358
NSC337251
NSC760358
p-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide hydrochloride
Pharmakon1600-01506043
Q-201730
S 0278
s2509
SAM001246725
SAM001246990
SC-13317
SCHEMBL118761
SMR000326828
Sorine
Sorine (TN)
Sotacor
Sotalex
Sotalol (Betapace)
Sotalol (hydrochloride)
Sotalol HCL
Sotalol hydrochloride (JAN/USP)
Sotalol hydrochloride [USAN:USP]
Sotalol hydrochloride [USAN]
Sotalol Hydrochloride 1.0 mg/ml in Methanol (as free base)
Sotalol hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sotalol Monohydrochloride
Sotalol, HCl
Sotalol.HCl
Sotylize
SR-01000076116
SR-01000076116-2
SR-01000076116-3
SR-01000076116-8
ST24049297
SW197352-4
Tox21_111267
Tox21_200127
Tox21_501055
VIDRYROWYFWGSY-UHFFFAOYSA-N
WLN: WS1&MR DYQ1MY1&1 &GH

US Patents and Regulatory Information for sotalol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Inc SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 077070-002 Nov 4, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Covis Pharma Bv BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-005 Mar 14, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 077616-001 Feb 7, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Beximco Pharms Usa SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 207428-002 Oct 21, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Pharms SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075663-001 Nov 7, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 076883-002 Jul 26, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Pharms SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075663-003 Nov 7, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Julphar
US Army
Baxter
Farmers Insurance
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.